Preclinical Evaluation of <sup>68</sup>Ga-labeled RGD Peptide for Detection of Malignant Angiogenesis
Introduction. The early detection of tumor growth remains one of the most important tasks of diagnostic nuclear medicine. The vascular growth being created malignant neoplasms is a good target for the purpose. The molecular participants in the process are gallium-68 labeled vector to the delivery of...
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | Russian |
| Foilsithe / Cruthaithe: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2020-08-01
|
| Sraith: | Разработка и регистрация лекарственных средств |
| Ábhair: | |
| Rochtain ar líne: | https://www.pharmjournal.ru/jour/article/view/833 |